With a special wish to all of you, we want to share, in the words of Donato Bonifazi, CEO at CVBF, some of our goals in the 2020 and wish you a Merry Christmas and a Healthy 2021.
<<We are approaching the end of a year, full of challenges, but also of activities and achievements for CVBF.
We are continuing the conduction of clinical trials in the best possible way, despite any difficulties and issues due to the pandemic. So far, we have 34 active projects among which I would like to mention two H2020 founded multinational clinical trials, cASPerCF – Finding the right dose of posaconazole for children & young people with Cystic Fibrosis and Aspergillus infection (sponsored by Bambino Gesù Children’s Hospital, within c4c) and AMELIE – Anchored Muscle cELls for IncontinencE (sponsored by University College of London).
Moreover, we are providing our contribution as CVBF in the fight against COVID-19 emergency by supporting the University of Pittsburgh Medical Center (UPMC) in two studies on COVID-19 aimed to test two vaccines in the form of a patch (protein subunit) and an intranasal spray (Adenovirus). PittCoVacc studies are both phase I / II clinical trials on healthy volunteers.
In the meanwhile, CVBF has successfully overcome 3 days of Good Clinical Practice (GCP) Inspection by the Italian Medicines Agency (AIFA).
During this pandemic emergency, we have experienced what a lack of an efficient health system means for everybody, and we are actively working to provide safe and affordable medicines for all, as it is underlined in the Pharmaceutical Strategy developed by the EU Commission, for which we have provided our comments to the Public Consultation. In this context, we have underlined the necessity to stress new adequate health policies and actions promoting the development and the access to safe and efficacious medicines, particularly for children.
Going back to a couple of weeks ago, I’m pleased to thank AICRO, the Italian Association of Clinical Research Organisations, which I’ve been chairing for three years so far, together with all the associations and scientific organisations supporting the organisation of the AICRO annual event on December 10th named “Menti a Contatto”, for giving me the chance to introduce the event with a presentation on “How Innovation can Accelerate the Clinical Research”.
In 2020, CVBF has been actively engaged in several EUCROF’s activities, from the working groups (Clinical Trial Centers, Communication, Outsourcing, Patients, Paediatric WGs) to the task forces (Code of Conduct, e-Consent, Funding, Patients’ data TFs), from the publications to the international events, such as the preparatory work for the next EUCROF conference that will be held in Madrid in 2022. Particularly, in my role of the EUCROF Events and Training working group Chair I’ve pursued the organisation of the 8 webinars this year, aimed to discuss the key issues impacting clinical research and to enhance professional competences.
Moreover, CVBF is proactively involved in the three main European infrastructural research projects dedicated to the development of medicines for paediatric and rare diseases patients, such as the European Joint Programme for Rare Diseases (EJP RD), the COllaborative Network for European Clinical Trials For Children (c4c) and the Paediatric Clinical Research Infrastructure Network (PedCRIN). CVBF participation to INCiPiT, the Italian Network for Paediatric Clinical Trials, is very relevant in this context, giving us the chance to develop effective cooperation with many non-profit research organisations as a non-profit CRO that supports numerous academic sponsors, particularly, but not only, in the paediatric field.
In the hope of living a more Healthy 2021, we wish you Happy Holidays!>>